Literature DB >> 31018947

Transcriptomic Characterization, Chemosensitivity and Regulatory Effects of Exosomes in Spontaneous EMT/MET Transitions of Breast Cancer Cells.

Elisabetta Bigagli1, Lorenzo Cinci2, Mario D'Ambrosio2, Cristina Luceri2.   

Abstract

BACKGROUND/AIM: We examined the gene expression changes of breast cancer cells spontaneously undergoing epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial transition (MET) and the role of exosomes in these transitions.
MATERIALS AND METHODS: Highly invasive mesenchymal-like breast cancer cells, MDA-MB-231 (basal cells), EMT and MET variants, were characterized by microarray gene expression profiling, immunocytochemistry and chemo-sensitivity.
RESULTS: Spontaneously disseminated cells were anoikis resistant, exhibited a dissociative, EMT-like phenotype and underwent MET when reseeded in cell-free plates. MET was inhibited by exosomes secreted by basal cells. Chemo-sensitivity to doxorubicin, vincristine and paclitaxel decreased in the order EMT<MET<basal. Phenotypic plasticity arose with differential expression of metastasis and stemness associated genes (LGR5, FZD10, DTX1, ErbB3, FTH1 and DLL4) and pathways (DNA replication and repair, ABC transporter, Hedgehog, Notch and metabolic pathways).
CONCLUSION: This is an appropriate model for studying EMT/MET transitions, drug targets and the role of exosomes in breast cancer dissemination. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; chemoresistance; epithelial–mesenchymal transition (EMT); exosomes; mesenchymal–epithelial transition (MET); metastasis

Mesh:

Substances:

Year:  2019        PMID: 31018947      PMCID: PMC6542641          DOI: 10.21873/cgp.20122

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  9 in total

1.  Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.

Authors:  Guanghui Wang; Wei Zhao; Huxia Wang; Guanglin Qiu; Zhengdong Jiang; Guangbing Wei; Xuqi Li
Journal:  Med Sci Monit       Date:  2019-09-25

2.  Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis.

Authors:  Yu Jin; Yalin Kang; Minghuan Wang; Bili Wu; Beibei Su; Han Yin; Yang Tang; Qianxia Li; Wenjie Wei; Qi Mei; Guangyuan Hu; Veronika Lukacs-Kornek; Jian Li; Kongming Wu; Xianglin Yuan; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

3.  Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents' Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma.

Authors:  Zeyu Wang; Ziyu Dai; Lifu Zheng; Binyuan Xu; Hao Zhang; Fan Fan; Xun Zhang; Xisong Liang; Zhixiong Liu; Kui Yang; Quan Cheng
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

Review 4.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02

5.  Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.

Authors:  April Zhang; Hira Aslam; Neha Sharma; Aryeh Warmflash; Walid D Fakhouri
Journal:  Cells Tissues Organs       Date:  2021-07-02       Impact factor: 2.208

Review 6.  Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

Review 7.  Proteomic Technology "Lens" for Epithelial-Mesenchymal Transition Process Identification in Oncology.

Authors:  Monica Neagu; Carolina Constantin; Marinela Bostan; Constantin Caruntu; Simona Rebeca Ignat; Sorina Dinescu; Marieta Costache
Journal:  Anal Cell Pathol (Amst)       Date:  2019-10-29       Impact factor: 2.916

Review 8.  Exosomes and breast cancer drug resistance.

Authors:  Xingli Dong; Xupeng Bai; Jie Ni; Hao Zhang; Wei Duan; Peter Graham; Yong Li
Journal:  Cell Death Dis       Date:  2020-11-17       Impact factor: 8.469

Review 9.  Metabolic Constrains Rule Metastasis Progression.

Authors:  Niccolo' Roda; Valentina Gambino; Marco Giorgio
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.